Our Team

Michael Bardash

Michael Bardash received an electrical engineering PhD from Cornell University with a major in Quantum Electronics. In 1994, Dr. Bardash founded QEL Inc. to develop components for an imaging system based on ultra-short x-ray pulses and ultra-fast detectors, successfully developing specialty radiation detectors with a sub-picosecond rise time. Dr. Bardash has taken several software related products to market. As a faculty member at Columbia University, Dr. Bardash was part of the first group to do treatment and planning for linear accelerator based stereotactic radio-surgery in New York. Dr. Bardash began working on tissue equivalent radiation detection devices in 1997 and founded Radiation Detection Solutions with Mr. Nico Sidoti in 2011.

Don Lincoln

Dr. Lincoln received a M.S. in Mechanical Engineering from the University of Nebraska and a PhD Engineering from the University of New Mexico with a specialization in thermal sciences. Dr. Lincoln is President of nStone Corporation and is a principal with Radiation Detection Solutions (RDS). Dr. Lincoln has founded a number of start-ups including the Gensys Corporation and the COGNET Group where he consulted for the Departments of Energy and Defense. The Genysy Corporation and COGNET Group also assisted commercial nuclear power stations develop radiation protection and emergency preparedness programs, as well as information systems to support nuclear power station system engineering. At nStone Corporation, Dr. Lincoln supports national laboratories in radiological materials control programs and assessments. Dr. Lincoln joined RDS in 2016 through the introduction of Mr. Jim Carter.

James E. Carter

Mr. Carter is a management consultant, entrepreneur, engineer, attorney, former navy nuclear submarine officer and former executive with degrees in engineering, business and law. As a Radiological Controls Officer in the navy nuclear submarine service, Mr. Carter was responsible for all shipboard radiation monitoring, control and management. He has managed large capital projects, grown existing businesses, founded several businesses, and served as commercialization mentor to small business technologies emanating from the Oak Ridge National Laboratory (ORNL). Mr. Carter also serves as an evaluator/judge for the Oak Ridge National Laboratory’s Innovation Crossroads program, which offers energy innovators the opportunity to leverage ORNL R&D resources to turn their innovative clean energy ideas into commercially viable companies. Mr. Carter is past chairman of Pathway Lending Inc., a Community Development Financial Institution focusing on financing small and early-stage businesses. He has served on the Board of Directors of NuScale Power Inc. a startup company commercializing advanced Small Modular Reactor (SMR) power generation technology.

Nico Sidoti

Nico Sidoti co-founded RDS with Dr. Bardash in 2011. Mr. Sidoti has started a number of light manufacturing print and packaging businesses. His current focus is on innovative print technology using unique substances and unusual substrates. He has sales and marketing experience servicing large corporations and cultural institutions. Mr. Sidoti is proud to part of the RDS team and honored to see the National Science Foundation support the advancement of RDS’s technology.

Lawrence Rosenthal

Lawrence Rosenthal PhD, MD joins RDS as part of the advisory team. Lawrence Rosenthal is a professor in Medicine at UMass Memorial Healthcare, in Worcester, Massachusetts. After attending Trinity college in Hartford, CT, he went on to graduate school at Clark University in Worcester, MA where he obtained his master’s and PhD in chemistry/biochemistry. He then went on to medical school at Albert Einstein College of Medicine in the Bronx, NY. His clinical training in medicine was done at UMass Medical Center and his training cardiology and electrophysiology was at The Johns Hopkins Hospital in Baltimore, MD. He has been at UMass since 1997. Originally trained as a basic scientist, with a focus on protein structure/function and genetics, he has transitioned over the years to focus clinical research and the understanding of clinical cardiac arrhythmias. He has a broad background in cardiac electrophysiology and device therapy. Annually, his center implants approximately 400 ICD’s, 400 pacemakers, and perform over 500 ablation procedures for atrial and ventricular arrhythmias. He has the expertise, leadership, training, and motivation necessary to successfully carry clinical research and has been active as the PI in many clinical studies, funded both privately and by the NIH. Finally, he has mentored over 20 fellows in cardiac electrophysiology. They have all gone on to be successful clinicians, researchers and leaders in the field of electrophysiology.